MENU
VCEL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Vericel (VCEL) Earnings Date & Reports

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets... Show more

A.I. Advisor
published Earnings

VCEL is expected to report earnings to fall 622.00% to 5 cents per share on November 06

Vericel VCEL Stock Earnings Reports
Q3'25
Est.
$0.05
Q2'25
Beat
by $0.02
Q1'25
Missed
by $0.10
Q4'24
Beat
by $0.07
Q3'24
Beat
by $0.03
The last earnings report on July 31 showed earnings per share of 0 cents, beating the estimate of -2 cents. With 3.04K shares outstanding, the current market capitalization sits at 1.79B.
View a ticker or compare two or three
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VCEL showed earnings on July 31, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of patient-specific expanded cellular therapies for use in the treatment of patients with diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
64 Sidney Street
Phone
+1 617 588-5555
Employees
314
Web
https://www.vcel.com